tirzepatide weight loss surmount-1 results percent weight loss 72 weeks Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide weight loss timeline: what

Kits, and blends, cost more in total but can work out cheaper per milligram

2013;24(2):8591 (PubMed PMID: 23332584

That 36.6-pound average, in people who had been diabetic for a mean of just 2.5 years, is a signal that the glucagon receptor component the distinguishing third arm of this GIP/GLP-1/glucagon triple agonist is doing real metabolic work beyond what dual agonism alone achieves

Understanding your genetic predispositions allows the clinical team to recommend whether standard semaglutide injection, oral formulations, or combination peptide therapy (like GLP-Squared) is most likely to work for your body